Cohance Lifesciences Grants Over 8.74 Lakh Stock Options

Cohance Lifesciences Ltd announced the grant of employee stock options (ESOPs) to eligible employees. The Nomination and Remuneration Committee approved the grant of 2,60,194 options under the ESOP 2026 plan and 6,14,594 options under the Suven Pharmaceuticals Limited – Employee Stock Option Plan 2023. The ESOP 2026 options have an exercise price not less than INR 325, with vesting between 1 to 8 years and exercise up to 3 years post-vesting. The ESOP 2023 options were granted at an exercise price of INR 495, with vesting between 1 to 10 years.